Immune 59: Forks in the road: Th17 cells with Mandy McGeachy
Immune
Isle 17 Is a Key Driver of T 17 Pathogencity
Every order immune disease people have identified, i also inten to be increased in various ways. The clinical trials that have been done haven't shown efficacy for amune system blockers such as isle 17 receptor. Blocking ile 23 thought to be one of the key drivers of t 17 sal pathogencity. Alsemty makes things worse.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
